Trust gold-standard PCR-based testing to keep moving forward

Prompt and early diagnosis of respiratory pathogens that cause severe illness is critical to help inform patient management, treatment decisions, and preventing the spread of disease.  Confidence in testing results allows clinicians and patients to make informed decisions—including seeking medical care and/or avoiding contact with other people.  While many testing options are available for respiratory testing, molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers. 

PCR and RADT are two testing technologies used to detect COVID-19. It’s important to understand what they each do best and how their attributes fit your testing scenario. The infographic below summarizes their differences. 

Download infographic  Browse kits

 

Rely on a tailored portfolio of TaqPath COVID-19 and flu testing solutions to meet your lab’s clinical testing needs

The US Food and Drug Administration (FDA) authorized the Applied Biosystems TaqPath COVID-19 Kit for emergency use just days after the World Health Organization (WHO) declared COVID-19 a global pandemic and later received the CE mark in Europe. Since then, Thermo Fisher Scientific has continued to grow and enhance the TaqPath testing portfolio by adding diagnostic kits for detection of COVID-19 in asymptomatic cases, direct from saliva, and simultaneous detection of flu A and flu B—all while enabling detection of all currently known variants and maintaining an uninterrupted product supply. 

TaqPath COVID-19 Combo Kit

TaqPath COVID-19 Combo Kit

Trusted worldwide—over half a billion tests distributed globally

Learn more ›

TaqPath COVID-19, Flu A, Flu B Combo Kit

TaqPath COVID-19, Flu A, Flu B Combo Kit

Single test—detect SARS-CoV-2 and influenza (flu) A and B viruses

Learn more ›

TaqPath COVID-19 RNase P Combo Kit 2.0

TaqPath COVID-19 RNase P Combo Kit 2.0

Sensitive detection for symptomatic and asymptomatic cases

Learn more ›

TaqPath COVID-19 Fast PCR Combo Kit 2.0

TaqPath COVID-19 Fast PCR Combo Kit 2.0

Fast direct from saliva + RNase P and mutation resilient

Learn more ›

For Emergency Use Authorization (EUA) only. For Prescription Use Only. For In Vitro Diagnostic Use.

Interested in the effect of mutations on sensitivity of the TaqPath COVID-19 diagnostic tests? Learn more ›

 

Looking for research solutions for investigating respiratory pathogens? Click below to view Research Use Only (RUO) products covering viral, bacterial, and fungal targets in targeted or syndromic panels.

For Research Use Only. Not for use in diagnostic procedures.

View RUO products

Multiple format and instrument options to meet your lab’s evolving throughput needs

The testing kits above are compatible with our portfolio of instruments and consumables listed below. Contact us for more information on the capabilities and compatibilities of multiple instruments and formats.

  • QuantStudio 5 Real-Time PCR system
  • QuantStudio 7 Flex Real-Time PCR system
  • 7500 Real-Time PCR system
  • 7500 Fast Dx Real-Time PCR system
  • TaqMan Array Plates (96-well, 384-well)

Contact us

For Emergency Use Authorization (EUA) Only. For Prescription Use Only. For In Vitro Diagnostic Use.

Style Sheet for Komodo Tabs
Style Sheet for Global Design System